Mapping the Progression of Therapy-Induced Senescence to Therapy Tolerance: An Evolutionarily Conserved Mechanism for Optimizing Cancer Treatment with Senotherapeutics. (PubMed, ACS Pharmacol Transl Sci) - Nov 20, 2025 - "However, this was most effective within a specific time window after TIS induction. We suggest that the timely use of senotherapeutics could improve the effectiveness of anticancer drugs in clinical settings."
Journal • Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • TGFB1
|
|
Alabhya Das; Anindita Chakrabarty; Gargi Mukherjee; Goutam Chowdhury; Kankonika Bhattacharyya; Muthumeena Ramanathan; Neha Dutta; Shaista Haider
|